Roney M

References (4)

Title : In-silico evaluation of diffractaic acid as novel anti-diabetic inhibitor against dipeptidyl peptidase IV enzyme - Roney_2025_In.Silico.Pharmacol_13_24
Author(s) : Roney M , Issahaku AR , Dubey A , Tufail A , Istiaque Hamim SM , Wilhelm A , Aluwi M
Ref : In Silico Pharmacol , 13 :24 , 2025
Abstract :
PubMedSearch : Roney_2025_In.Silico.Pharmacol_13_24
PubMedID: 39944121

Title : Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches - Roney_2025_3.Biotech_15_24
Author(s) : Roney M , Dubey A , Uddin MN , Issahaku AR , Tufail A , Tufail N , Wilhelm A , Aluwi M
Ref : 3 Biotech , 15 :24 , 2025
Abstract :
PubMedSearch : Roney_2025_3.Biotech_15_24
PubMedID: 39735612

Title : Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches - Roney_2025_Comput.Biol.Chem_116_108378
Author(s) : Roney M , Uddin MN , Khan AA , Fatima S , Mohd Aluwi MFF , Hamim SMI , Ahmad A
Ref : Comput Biol Chem , 116 :108378 , 2025
Abstract :
PubMedSearch : Roney_2025_Comput.Biol.Chem_116_108378
PubMedID: 39938415

Title : Insights from in silico exploration of major curcumin analogs targeting human dipeptidyl peptidase IV - Roney_2024_J.Biomol.Struct.Dyn__1
Author(s) : Roney M , Dubey A , Issahaku AR , Uddin MN , Tufail A , Wilhelm A , Zamri NB , Aluwi M
Ref : J Biomol Struct Dyn , :1 , 2024
Abstract :
PubMedSearch : Roney_2024_J.Biomol.Struct.Dyn__1
PubMedID: 38260948